Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting
Go back to Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting| (NASDAQ: KOD) | Delayed: 32.71 -0.14 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.85 | 52 Week High | $ | |||
| Open | $32.78 | 52 Week Low | $ | |||
| Day High | $32.82 | P/E | N/A | |||
| Day Low | $31.54 | EPS | $ | |||
| Volume | 1,608,964 | |||||
